By Priscila Mayumi Kashiwabara
July 5, 2021
Personalised medicine in Brazil: IP and regulatory challenges
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2021, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last by Priscila Mayumi Kashiwabara
December 2, 2024
Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
On November 27, 2024, the Chamber of Deputies approved Bill 466/2022, which addresses Brazil’s adhesion to the Budapest Treaty on the International … Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty
September 23, 2024
Priscila Kashiwabara will be attending “From Gene to Trait 2024” course
Our partner Priscila Kashiwabara will be one of the speakers at the “From Gene to Trait 2024” course. The event will take … Priscila Kashiwabara will be attending “From Gene to Trait 2024” course
September 9, 2024
Kasznar Leonardos wins LMG Life Sciences
We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! … Kasznar Leonardos wins LMG Life Sciences